Evaluation of treatment response with serial CT in patients with non-tuberculous mycobacterial pulmonary disease

被引:0
|
作者
Dettmer, Sabine [1 ,2 ]
Heiss-Neumann, Marion [3 ,4 ]
Wege, Sabine [5 ]
Maske, Hannah [1 ]
Ringshausen, Felix C. [2 ,6 ,7 ]
Joean, Oana [6 ]
Theissig, Nicole [5 ]
Ewen, Raphael [6 ]
Wacker, Frank [1 ,2 ]
Rademacher, Jessica [2 ,6 ]
机构
[1] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany
[2] Biomed Res Endstage & Obstructive Lung Dis Hannove, Hannover, Germany
[3] Asklepios Lung Clin Munich Gauting CPC M, Dept Pneumol & Infect Dis, Gauting, Germany
[4] German Ctr Lung Res DZL, Comprehens Pneumol Ctr Munich, Gauting, Germany
[5] Thoraxklin Univ Hosp Heidelberg, Dept Pneumol & Crit Care Med, Heidelberg, Germany
[6] Hannover Med Sch, Dept Resp Med & Infect Dis, Hannover, Germany
[7] European Reference Network Rare & Complex Resp Dis, Frankfurt, Germany
关键词
Computed tomography; Treatment response; Nontuberculous mycobacteria; Nontuberculous mycobacterial pulmonary disease; THIN-SECTION CT; COMPUTED-TOMOGRAPHY; LUNG-DISEASE; BRONCHIECTASIS; DIAGNOSIS; TUBERCULOSIS; INFECTION; CLAIMS;
D O I
10.1007/s00330-024-10987-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives In patients with non-tuberculous mycobacterial pulmonary disease (NTM-PD), the response to treatment is evaluated based on microbiological, clinical, and radiological data. However, little is known about the dynamics of CT findings. The aim of this study was to evaluate CT changes in NTM-PD in order to define radiological criteria for treatment success. Methods Retrospective multicenter study (Hannover, Heidelberg, Gauting). Sixty patients with NTM-PD and at least two consecutive CT scans were included. Scoring for NTM-PD was performed by evaluating variables of bronchiectasis, mucus plugging, bronchiolitis, cavities, nodules, and consolidations on an ordinal scale from 0 to 3. Differences between baseline and follow-up were calculated, and patients with/without cultural conversion were compared using the Mann-Whitney U-test. For paired comparison of the two consecutive CT scans the Wilcoxon test was used. Results Comparing patients with and without culture conversion, there were significant differences in temporal changes of bronchiectasis (p < 0.001), cavities (p = 0.006), bronchiolitis (p < 0.001), consolidations (p = 0.004), and total score (p < 0.001). Nodules showed no significant differences between groups (p = 0.060). The Wilcoxon test showed significant differences between both CTs in patients with a microbiological cure for the total score (p < 0.001), cavities (p = 0.005), bronchiolitis (p < 0.001), and consolidations (p = 0.021) with a decrease after microbiological cure, whereas bronchiectasis (p = 0.102) and nodules (p = 0.18) stayed stable. In the case of persistently positive cultures, there was an increase in the total score (p = 0.010) which was attributable to progressive bronchiectasis (p < 0.001). Conclusion Cavities, consolidations, and bronchiolitis are useful to assess treatment response, whereas bronchiectasis and nodules may remain stable despite successful treatment. Clinical relevance statement Cavities, consolidations, and bronchiolitis can assess treatment response whereas bronchiectasis and nodules may remain stable despite successful treatment. In persistently positive cultures, bronchiectasis showed an increase over time indicating that NTM-PD is a progressive chronic disease.
引用
收藏
页码:798 / 805
页数:8
相关论文
共 50 条
  • [1] Nationwide evaluation of treatment outcomes and survival of patients with non-tuberculous mycobacterial pulmonary disease
    Makek, M. J.
    Glodic, G.
    Sabol, I.
    Zmak, L.
    Samarzija, M.
    Sola, A.
    Marusic, A.
    Marekovic, I.
    Bulat, L. K.
    Corak, L.
    Obrovac, M.
    van Ingen, J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (10)
  • [2] EVALUATION OF CHEMOTHERAPY FOR PULMONARY NON-TUBERCULOUS MYCOBACTERIAL DISEASE
    Sato, Masamichi
    Abe, Shuichi
    Abe, Yuki
    Sato, Kento
    Nemoto, Takako
    Nunomiya, Keiko
    Kimura, Tomomi
    Yamauchi, Keiko
    Igarashi, Akira
    Inoue, Sumito
    Shibata, Yoko
    Kubota, Isao
    RESPIROLOGY, 2014, 19 : 212 - 212
  • [3] Non-tuberculous mycobacterial pulmonary disease
    Cowman, Steven
    van Ingen, Jakko
    Griffith, David E.
    Loebinger, Michael R.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
  • [4] PULMONARY NON-TUBERCULOUS MYCOBACTERIAL DISEASE
    PLIT, ML
    WOOLF, M
    MILLER, GB
    SOUTH AFRICAN MEDICAL JOURNAL, 1988, 74 (05): : 217 - 219
  • [5] NON-TUBERCULOUS MYCOBACTERIAL PULMONARY-DISEASE
    SPITZ, HB
    WIOT, JF
    SEMINARS IN ROENTGENOLOGY, 1979, 14 (03) : 244 - 248
  • [6] Plasma cytokine levels as markers of pathogenesis and treatment response in patients with non-tuberculous mycobacterial pulmonary disease
    Zhao, Sai
    Zhang, Zhiqiang
    Xu, Jie
    Zhou, Zheng
    Wu, Yunhua
    Wu, Yanhua
    Jiang, Guosheng
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2024, 57
  • [7] Immune response against TB and non-tuberculous mycobacterial pulmonary disease
    Adankwah, E.
    Arthur, R. A.
    Minadzi, D.
    Owusu, D. O.
    Phillips, R. O.
    Jacobsen, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (03) : 234 - 236
  • [8] Safety of intravenous amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease
    Ellender, Claire
    Eather, Geoffrey
    Konstantinos, Anastasios
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [9] Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease
    Ellender, Claire M.
    Law, Dayna B.
    Thomson, Rachel M.
    Eather, Geoffrey W.
    RESPIROLOGY, 2016, 21 (02) : 357 - 362
  • [10] Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease
    Naito, Maiko
    Kurahara, Yu
    Yoshida, Shiomi
    Ikegami, Naoya
    Kobayashi, Takehiko
    Minomo, Shojiro
    Tachibana, Kazunobu
    Tsuyuguchi, Kazunari
    Hayashi, Seiji
    Suzuki, Katsuhiro
    RESPIRATORY INVESTIGATION, 2018, 56 (04) : 326 - 331